CHAMPIONS ONCOLOGY, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CHAMPIONS ONCOLOGY, INC. stock issued during period, value, other for the quarter ending 2026-07-31 was $52.00K, a 116.67% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. stock issued during period, value, other for the quarter ending 2026-01-31 was $3.00K, a 91.89% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. stock issued during period, value, other for the quarter ending 2025-10-31 was $207.00K, a 25.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. stock issued during period, value, other for the quarter ending 2025-07-31 was $24.00K, a 91.30% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. stock issued during period, value, other for fiscal 2026 was $234.00K, a 26.88% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. stock issued during period, value, other for fiscal 2025 was $320.00K, a 26.48% increase from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. stock issued during period, value, other for fiscal 2024 was $253.00K, a 197.65% increase from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. stock issued during period, value, other for fiscal 2023 was $85.00K, a 59.13% decline from fiscal 2022.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-07-31 | $52.00K 10-Q · filed 2026-09-11 | |
| 2026-04-30 | $234.00K 10-K · filed 2026-07-27 | |
| 2026-01-31 | $3.00K 10-Q · filed 2026-03-12 | |
| 2025-10-31 | $207.00K 10-Q · filed 2026-03-12 | |
| 2025-07-31 | $24.00K 10-Q · filed 2026-09-11 | |
| 2025-04-30 | $320.00K 10-K · filed 2026-07-27 | |
| 2025-01-31 | $37.00K 10-Q · filed 2026-03-12 | |
| 2024-10-31 | $276.00K 10-Q · filed 2026-03-12 | |
| 2024-07-31 | $276.00K 10-Q · filed 2024-12-16 | |
| 2024-04-30 | $253.00K 10-K · filed 2025-07-23 | |
| 2023-10-31 | $240.00K 10-Q · filed 2025-03-17 | |
| 2023-07-31 | $12.00K 10-Q · filed 2025-03-17 | |
| 2023-04-30 | $85.00K 10-K · filed 2024-07-19 | |
| 2022-10-31 | $86.00K 10-Q · filed 2024-03-15 | |
| 2022-04-30 | $208.00K 10-K · filed 2023-07-24 | |
| 2022-01-31 | $68.00K 10-Q · filed 2023-03-16 | |
| 2021-10-31 | $122.00K 10-Q · filed 2023-03-16 | |
| 2021-07-31 | $2.00K 10-Q · filed 2023-03-16 | |
| 2021-04-30 | $1.37M 10-K · filed 2022-07-22 | |
| 2021-01-31 | $2.00K 10-Q · filed 2022-03-15 | |
| 2020-10-31 | $1.29M 10-Q · filed 2022-03-15 | |
| 2020-07-31 | $0.00 10-Q · filed 2021-03-15 | |
| 2020-04-30 | $4.46M 10-K · filed 2021-07-26 | |
| 2020-01-31 | $427.00K 10-Q · filed 2021-03-15 | |
| 2019-10-31 | $2.00K 10-Q · filed 2021-03-15 | |
| 2019-04-30 | $1.47M 10-K · filed 2020-07-28 | |
| 2019-01-31 | $365.00K 10-Q · filed 2020-03-16 | |
| 2018-10-31 | $1.03M 10-Q · filed 2020-03-16 | |
| 2018-07-31 | $42.00K 10-Q · filed 2020-03-16 | |
| 2018-04-30 | $38.00K 10-K · filed 2019-07-29 | |
| 2017-04-30 | $4.34M 10-K · filed 2018-07-30 | |
| 2016-04-30 | $44.00K 10-K · filed 2016-07-29 | |
| 2015-04-30 | $11.16M 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |